AR121189A2 - ANTI-TIGIT ANTIBODIES AND METHODS OF USE - Google Patents
ANTI-TIGIT ANTIBODIES AND METHODS OF USEInfo
- Publication number
- AR121189A2 AR121189A2 ARP210100111A ARP210100111A AR121189A2 AR 121189 A2 AR121189 A2 AR 121189A2 AR P210100111 A ARP210100111 A AR P210100111A AR P210100111 A ARP210100111 A AR P210100111A AR 121189 A2 AR121189 A2 AR 121189A2
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- tigit antibodies
- tigit
- antibodies
- domained
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente se refiere a anticuerpos anti-TIGIT (inmunoreceptor de células T con dominios de Ig e ITIM) y métodos de uso de los mismos.The present relates to anti-TIGIT (Ig- and ITIM-domained T-cell immunoreceptor) antibodies and methods of use thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562233230P | 2015-09-25 | 2015-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR121189A2 true AR121189A2 (en) | 2022-04-27 |
Family
ID=60931770
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102929A AR106146A1 (en) | 2015-09-25 | 2016-09-26 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE |
| ARP210100111A AR121189A2 (en) | 2015-09-25 | 2021-01-18 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102929A AR106146A1 (en) | 2015-09-25 | 2016-09-26 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE |
Country Status (1)
| Country | Link |
|---|---|
| AR (2) | AR106146A1 (en) |
-
2016
- 2016-09-26 AR ARP160102929A patent/AR106146A1/en unknown
-
2021
- 2021-01-18 AR ARP210100111A patent/AR121189A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR106146A1 (en) | 2017-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018000595A1 (en) | Anti-PD1 antibodies and methods of use | |
| ZA202401297B (en) | Anti-tigit antibodies and methods of use | |
| CL2020002540A1 (en) | Anti-hla-g antibodies and their use | |
| CL2019002824A1 (en) | Anti-lag3 antibodies. | |
| CO2017013351A2 (en) | Cot modulators and methods of using them | |
| ECSP18007905A (en) | MONOCLONAL ANTIBODIES AGAINST BCMA | |
| MX2022001878A (en) | RECEPTOR COUPLED TO G PROTEIN DIRECTED TO ANTIBODIES AND METHODS OF USE. | |
| MX2017005920A (en) | Anti-tim3 antibodies and methods of use. | |
| CO2020012360A2 (en) | Multispecific antibodies and their use | |
| CR20150618A (en) | ANTITRANSPHERINE RECEIVING ANTIBODIES AND METHODS OF USE | |
| BR112015032224A2 (en) | anti-fcrh5 antibodies | |
| MX2015017341A (en) | Anti-complement factor c1q antibodies and uses thereof. | |
| MX386587B (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE. | |
| CR20160500A (en) | ANTI-OX40 ANTIBODIES AND METHODS OF USE | |
| CL2016002455A1 (en) | Multispecific antibodies. | |
| MX2017007585A (en) | Anti-c10orf54 antibodies and uses thereof. | |
| MX2016005631A (en) | ANTI-alpha-SYNUCLEIN ANTIBODIES AND METHODS OF USE. | |
| MX2017015042A (en) | Cd123 antibodies and conjugates thereof. | |
| MX372675B (en) | ANTI-JAGGED1 ANTIBODIES AND METHODS OF USE. | |
| CR20160270A (en) | ANTI-TAU ANTIBODIES (pS422) HUMANIZED AND USED METHODS | |
| CL2018001139A1 (en) | Anti-htra1 antibodies and methods of use thereof. | |
| AR121189A2 (en) | ANTI-TIGIT ANTIBODIES AND METHODS OF USE | |
| AR113854A1 (en) | ANTI-CXCR5 ANTIBODIES, COMPOSITIONS AND USES THEREOF |